Published Date: 19 Apr 2024
Legal experts suggest that legislation might offer protection from lawsuits.
Read Full NewsWomen living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according to a multiyear analysis involving more ...
In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...
Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets ...
1.
Team finds broken 'brake' on cancer mutation machine.
2.
Breast cancer: Why it's difficult to treat and what new approaches are on the horizon
3.
Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy
4.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
5.
Even when they are not paying attention, children are still learning.
1.
Navigating the Complexities of Esophageal Cancer Staging
2.
Cancer Vaccines In India: The Latest Hope In The Fight Against Disease
3.
Radiation Oncology: Integrating AI, Theranostics, and Adaptive Therapies for Personalized Cancer Care
4.
The Converging Frontiers of Radiation Oncology and Systemic Therapies by 2025
5.
Unlocking The Causes And Risk Factors Of Breast Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation